Sun Pharmaceutical Industries Limited

Sun Pharmacuetical Industries Ltd.

Kandarp Maheshkumar Dave

Samarth Kumar

Milan Natvarbhai Thakkar

Subhas Balaram Bhowmick

Prashant Kane

Rakesh Thummar

Shantaram Pawar

The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.

Parenteral dosage form of diltiazem

The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.

Parenteral dosage form of norepinephrine

A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.

Ready-to-administer solution of fentanyl citrate

Growing community of inventors

Baroda, India

Kandarp Maheshkumar Dave